Zynex hit by tricare suspension on multiple fronts: weak earnings and investor lawsuit - hagens berman

San francisco, ca / access newswire / may 6, 2025 / medical technology company zynex, inc. (nasdaq:zyxi) is facing a double whammy linked to its dealings with tricare, the healthcare program for the u.s. military community. the company's first-quarter 2025 results revealed a sharp downturn, largely attributed to a temporary payment suspension by one of its major payers, tricare.
ZYXI Ratings Summary
ZYXI Quant Ranking